Table 2 Basic information on ADEs related to ganirelix from the FAERS database
Characteristics | Case number | Case proportion, % |
|---|---|---|
Sex | ||
Female | 1096 | 100% |
Age < 18 years | 1 | 0.1% |
18–65 years | 662 | 60.4% |
Unknown | 433 | 39.5% |
Weight < 50 kg | 26 | 2.4% |
50–100 kg | 129 | 11.8% |
> 100 kg | 51 | 0.5% |
Unknown | 937 | 85.5% |
Reported Countries (top five) US | 597 | 54.5% |
DE | 179 | 16.3% |
FR | 127 | 11.6% |
JPN | 50 | 4.6% |
NL | 35 | 3.2% |
Reported person Health professionals | 724 | 66.1% |
Consumer | 362 | 33.0% |
Unknown | 10 | 0.9% |
Outcome | ||
HO | 359 | 32.8% |
LT | 15 | 1.4% |
DS | 5 | 0.5% |
DE | 2 | 0.2% |
OT | 143 | 13.0% |
CA | 1 | 0.1% |
Unknown | 571 | 52.1% |
Indication (top five) | ||
Infertility female | 187 | 17.1% |
In vitro fertilization | 149 | 13.6% |
Assisted reproductive technology | 136 | 12.4% |
Infertility | 85 | 7.8% |
Prevention of premature ovulation | 56 | 5.1% |